Navigate Up
HANC Logo
The HIV/AIDS Network Coordination (HANC) project works with the six HIV/AIDS clinical trials networks funded by the Division of AIDS (DAIDS) of the U.S. National Institutes of Health (NIH) with the intent of creating a more integrated, collaborative and flexible research structure. The networks are an affiliated group of national and international medical research institutions and investigators that conduct clinical HIV/AIDS research to develop safe and effective drugs, prevention strategies, and vaccines.
 
 

photo

​Get Involved in HIV/AIDS Clinical Trials

Learn more about participating in a clinical research study or engaging your community in clinical trials research.

Calandar Image

HANC Calendar

​Check for scientific conferences, network meetings, community events, training dates, etc. 

Training Resources

​View a variety of training resources including the online HIV Research Counseling and Testing (HRCT) curriculum, HSP and GCP training.

Lab Resources

​Find info for labs such as procedures and SOPs.

​Legacy Project

Learn how HANC is working to increase participation of African Americans and Hispanics in HIV clinical trials.

HANC is supported by:

Link to US Dept. of Health and Human Services Link to National Iinstitutes of Health Link to DAIDS Link to FHCRC

Find us, follow us, friend us:

Link to HANC Facebook page Link to HANC Twitter feed

Announcements

New Be the Generation Bridge Partners Awarded.

Be the Generation Bridge (BTG Bridge), a National Institute of Allergy and Infectious Diseases (NIAID) funded collaborative effort between FHI 360 and Legacy Project is pleased to announce the newly selected BTG Bridge partners. BTG Bridge awarded 18 local and national organizations identified as being capable of helping meet the goals of the BTG Bridge Partnership Project.

RFAs for the 5 NIAID HIV/AIDS leadership groups are now posted

Deadline for submission is September 28, 2012.

New Job Posting:

The National Institute of Allergy and Infectious Diseases seeks an exceptional and visionary leader to take on the role of director, Office for Policy in Clinical Research Operations (OPCRO) in the Division of AIDS (DAIDS). The OPCRO director serves as a key advisor to the DAIDS director and to scientific programs on all clinical research oversight issues; provides objective, experience-based guidance and oversight; and is responsible for identifying and resolving a variety of complex clinical trials management, policy and administrative issues. Closes January 31, 2012. 

MTN to Discontinue Use of Tenofovir Gel in VOICE, A Major HIV Prevention Study in Women.

VOICE, an HIV prevention trial that has been evaluating two antiretroviral (ARV)-based approaches for preventing the sexual transmission of HIV in women - daily use of one of two different ARV tablets or of a vaginal gel - will be dropping the vaginal gel from the study.

New HPTN Announcement:

Scholarship opportunity in HIV Research for Minority Investigators

The Behavioral Science Working Group reports are now available.

Two Pivotal Studies Show PrEP Can Reduce HIV Infection in Heterosexuals

Partners PrEP and CDC TDF2  show promising results for PrEP's effectiveness in preventing HIV transmission.

DAIDS Network Studies and EAE Reporting Manual Listing - Now Available!

This new reference table indicates study EAE Manual reporting status.

 

 

 

 

 

 

 

Digg Delicious Facebook Newsvine Reddit StumbleUpon Twitter Email Link

share:

SiteMap

sitemap:

© HIV/AIDS Network Coordination